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FRETIt has been shown that the genomes of episomally maintained DNA viruses are tethered to host cell
chromosomes during cell division, facilitating maintenance in dividing cells. The papillomavirus E2 protein
serves this mechanism of viral genome persistence by simultaneously associating with chromatin and the
viral genome during mitosis. Several host cell proteins are reported to be necessary for the association of E2
with chromatin including the cohesion establishment factor ChlR1. Here we use ﬂuorescence resonance
energy transfer (FRET) technology to conﬁrm the interaction between BPV-1 E2 and ChlR1. Furthermore, we
use synchronised live cells to study the temporal nature of this dynamic protein interaction and show that
ChlR1 and E2 interact during speciﬁc phases of the cell cycle. These data provide evidence that the association
of E2 with ChlR1 contributes to a loading mechanism during DNA replication rather than direct tethering
during mitotic division..
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Human papillomaviruses (HPVs) are the aetiological agents of
benign and malignant lesions of differentiating cutaneous and
mucosal squamous epithelium. Infection with high risk HPV types,
for example HPV-16 and HPV-18, is linked to the progression of the
majority of cervical cancers, in addition to a substantial subset of other
anogenital and head and neck carcinomas (zur Hausen, 2009).
Approximately 100 HPV types have been isolated, each classiﬁed
depending on their infection site preference and clinical outcome (de
Villiers et al., 2004).
The PV life cycle is intimately linked to the differentiation of
epithelial cells. Infection is established in the basal cells of the
epitheliumwhere the genome ismaintained as an extra-chromosomal
episome that replicates along with the cellular DNA during S phase
(Kadaja et al., 2009). Viral replication requires the viral E1 and E2
proteins, which together melt the origin of replication and recruit
cellular proteins required for replication such as replication protein A
and DNA polymerase α primase (Conger et al., 1999; Han et al., 1999;
Loo and Melendy, 2004; Masterson et al., 1998). E2 functions in the
transcriptional regulation of early gene expression (Gloss and Bernard,
1990; Spalholz et al., 1988). As infected cells differentiate, theymigrate
away from the basal layer and into the upper layers of the epidermis.Late gene expression is then activated allowing expression of capsid
proteins and assembly of infectious virions.
Throughout the viral life cycle, the approximately 8000 base pair
PV genomes are stably maintained as autonomous, multi-copy
circular double-stranded DNA plasmids. The PV genome does not
encode a canonical centromeric region (Calos, 1998) and therefore
cannot assemble kinetochore-like structures that could be used to
facilitate genome segregation during mitosis. The segregation of
episomal viral genomes into daughter cells is an obstacle that all low-
copy number episomal viruses should overcome in order to maintain
viral persistence (Feeney and Parish, 2009). The PV E2 protein serves
this function by tethering PV episomes to mitotic chromosomes
(Bastien and McBride, 2000; Skiadopoulos and McBride, 1998),
although the speciﬁc mechanism remains unresolved.
The E2 protein encoded by all papillomavirus types is around 42 kDa
in size and contains a C-terminal DNA binding and dimerisation domain
and an N-terminal transactivation domain. These functional domains
are linked by a ﬂexible hinge region (Hegde, 2002). To facilitate viral
genome tethering during mitosis, it is thought that the C-terminal DNA
binding domain of E2 speciﬁcally binds to consensus sequences within
the viral genome while associating with host cell chromosomes via its
N-terminal domain (Bastien and McBride, 2000; Skiadopoulos and
McBride, 1998).However, it has been shown that thedimerisation of E2,
facilitated at the C-terminus of the protein, seems to be required for the
efﬁcient interaction of E2 with host cell chromosomes (Cardenas-Mora
et al., 2008). TheN-terminal domain of E2 does not itself directly bind to
DNA and as such E2 targets host cell chromatin associated protein(s) to
facilitate tethering. Several host cell proteins have been reported to act
as a chromatin receptor for E2 during mitosis.
2 Rapid CommunicationThe bromodomain family member, Brd4 was ﬁrst identiﬁed as the
chromatin binding receptor for E2 (You et al., 2004). Brd4 is a member
of the BET family of transcriptional regulators and binds to DNA by
interacting with acetylated H3 and H4 histones through its two
bromodomains (Dey et al., 2003). Brd4 has been shown to diffusely
coat the surface of mitotic chromosomes and expression of E2 results
in recruitment of Brd4 to punctate foci that co-localise with E2
throughout mitosis (Abbate et al., 2006; McPhillips et al., 2005; You
et al., 2004). In addition, the over-expression of the C-terminal
domain of Brd4 that contains the E2 binding site results in a loss of
viral genomes. Interestingly, it has been demonstrated that Brd4
interaction is also important for E2-dependent transcription regula-
tion and viral genome replication, suggesting that this interaction
plays an important role in multiple processes in the viral life cycle
(Ilves et al., 2006; Schweiger et al., 2006; Senechal et al., 2007; Wu
and Chiang, 2007; Wu et al., 2006). In addition, it has been
demonstrated that association of E2 with Brd4 is not required for
genome partitioning of all papillomavirus types (McPhillips et al.,
2006) and that depletion of Brd4 has no effect on the association of E2
with mitotic chromosomes (Parish et al., 2006a). Put together these
data suggest a role for Brd4 in viral genome tethering, but that Brd4
interaction may not be essential for this important process.
A second cellular protein implicated in the E2-dependent tethering
of viral genomes during mitosis is the topoisomerase binding protein
TopBP1. An interaction between HPV-16 E2 and TopBP1 was identiﬁed
(Boner et al., 2002) andTopBP1was subsequently shown to regulate the
afﬁnity of E2 with cellular chromatin. Furthermore E2 and TopBP1 co-
localise on mitotic chromosomes at late stages of mitosis, further
substantiating the hypothesis that TopBP1 plays a role in E2-mediated
viral genome tethering. In addition to these studies,wehave isolated the
DNA helicase, ChlR1 as a cellular binding protein of E2 (Parish et al.,
2006a). ChlR1 plays a role in sister chromatid cohesion establishment
and as such is important in the accurate segregation of cellular
chromosomes during mitosis (Inoue et al., 2007; Parish et al., 2006b).
In order to deﬁne the role of ChlR1 interaction in the viral life cycle, we
isolated a mutant of BPV-1 E2 (W130R) that fails to associate with
ChlR1. E2W130R retains important functions towild type levels such as
transcriptional activation and viral genome replication. In addition, E2
W130R associates with known binding partners of E2 such as E1, Brd4,
Gps2 (Breiding et al., 1997; Grossel et al., 1996; Parish et al., 2006a) and
TopBP1 (Parish, unpublished). Using E2 W130R, we determined that
ChlR1 interaction was required for the association of E2 with
chromosomes and stable genome maintenance in dividing cells. To
conﬁrm these data we used RNA interference to deplete endogenous
ChlR1 protein, which resulted in an abrogation of the association of E2
with mitotic chromosomes. These studies demonstrate that interaction
with ChlR1 is required for viral genome tethering to mitotic chromo-
somes. However, we hypothesise that ChlR1 itself is not the mitotic
tether for E2 since these two proteins do not co-localise on mitotic
chromosomes; ChlR1 associates with chromosomes during the very
early stages of mitosis only. These observations strongly suggest that
ChlR1 is required for the loading of E2-associated viral genomes onto
chromosomes during DNA replication at S-phase, but not for their
retention during mitosis. To conﬁrm this hypothesis, we have used co-
immunoprecipitation assays and ﬂuorescence resonance energy trans-
fer (FRET) technology in live cells synchronised at speciﬁc stages of the
cell cycle to analyse the temporal nature of the interaction between
ChlR1 and BPV-1 E2.
Results
Characterisation of BPV-1 E2 and ChlR1 fusion proteins
The bovine papillomavirus type 1 (BPV-1) E2 protein has been
shown to co-localise with endogenous ChlR1 protein in the nucleus,
with nucleolar exclusion in the African green monkey kidney CV-1 cellline (Parish et al. 2006a). Here, hTERT immortalised retinal pigment
epithelial cells (hTERT-RPE1) were used to assess the interaction
betweenChlR1–YFP and E2–CFP fusion proteins. hTERT-RPE1 cellswere
used throughout the present study for several reasons. Firstly, they are a
human epithelial cell line and are therefore similar in origin to other cell
lines that have historically been used to study papillomavirus protein
function. In addition, hTERT-RPE1 cells are functionally and phenotyp-
ically normal and are arrested by serum deprivation, contact inhibition
and cell cycle inhibitors such as thymidine and nocodazole (Jiang et al.
1999). Therefore tight cell cycle synchronisation of these cells can be
achieved, allowing the study of cell cycle dependent protein in-
teractions. To assess the expression and localisation of ChlR1–YFP and
E2–CFP in hTERT-RPE1 cells, cells were co-transfected and the
subcellular localisation of each fusion protein assessed by direct
ﬂuorescence using confocal microscopy (Fig. 1A). E2–CFP and ChlR1–
YFP are localised to the nuclear compartment with nucleolar exclusion
as previously described for the native proteins, showing that the
ﬂuorescent tags do not affect protein targeting to the nuclear
compartment. Some cytoplasmic expression was visible in cells
expressing higher amounts of the fusion proteins. In addition, an E2
protein containing a pointmutant at position tryptophan 130 (W130R),
previously shown to be unable to bind to ChlR1 while retaining wild
type transcription activation and replication functions of E2 (Breiding
et al., 1997; Grossel et al., 1996; Parish et al., 2006a), was expressed as a
CFP fusion protein (E2W130R–CFP). Like E2–CFP, E2W130R–CFP co-
localised with ChlR1–YFP in the nucleus of co-transfected cells with
nucleolar exclusion. To ensure that the fusion proteins were correctly
expressed, Western blot analysis using B201 and ChlR1 antibodies
respectively conﬁrmed that the E2–CFP, E2W130R–CFP and ChlR1–YFP
fusion proteins are the appropriate size (Figs. 1C, 3 and 5B).
Toprovide evidence that the E2 fusionproteins used in this study are
able to bind DNA and retain wild type E2 transactivation activity, the
ability of E2–CFP to activate transcription from a synthetic Luciferase
reporter plasmid was compared to wild type E2 protein. hTERT-RPE1
cells were transfected with reporter alone or in combination with
increasing amounts of E2 expression plasmid. The data in Fig. 1B and C
clearly show that E2–CFP is able to activate transcription in a dose
responsive manner to levels comparable to wild type E2 protein,
indicating that the transcription activation functionof E2 is not impaired
by the addition of the C-terminal ﬂuorescent protein tag. Like E2–CFP,
E2W130R–CFP is also able to activate transcription in a dose responsive
manner to levels similar to wild type E2 (Fig. 1B).
Wehavepreviously shown thatChlR1 functions in theestablishment
of sister chromatid cohesion and that depletion of ChlR1 fromHeLa cells
results in abnormal sister chromatid cohesion (Parish et al, 2006b). To
provide evidence that the ChlR1–YFP fusion protein used in this study is
active and like native ChlR1, functions in the cohesion establishment
pathway, hTERT-RPE1 cells were transfected a siRNA oligonucleotide
that targets the 3′UTR of ChlR1 to deplete cells of endogenous ChlR1
protein, or a non-targeting siRNA oligonucleotide as a negative control.
In parallel, cells were co-transfected with ChlR1 siRNA and ChlR1–YFP
expression plasmid, which is insensitive to the 3′UTR speciﬁc ChlR1
siRNA. Cells were then blocked with nocodazole for 3 h before
harvesting for Western blot analysis and metaphase spread analysis to
assess sister chromatid cohesion. Transfection of cells with ChlR1-
speciﬁc siRNA resulted in efﬁcient depletion of ChlR1 protein as
compared to untransfected cells or cells transfected with non-targeting
siRNA. Co-transfection of cells with ChlR1 siRNA and ChlR1–YFP
expression plasmid resulted in depletion of endogenous ChlR1 protein
in conjunction with co-expression of exogenous ChlR1–YFP (Fig. 2A)
with approximately 70% of cells expressing ChlR1–YFP (data not
shown). Analysis of metaphase spreads generated from the same
transfected cell populations revealed that while cells transfected with
non-targeting control siRNA showed normal sister chromatid cohesion,
cells with depleted ChlR1 protein had signiﬁcantly fewer metaphase
cells, presumably because hTERT-RPE1 cells will arrest at the G2
Fig. 1. Functional analysis of E2–CFP and ChlR1–YFP fusions. hTERT-RPE1 cells were co-transfected with pcDNA–E2–CFP and pcDNA–ChlR1–YFP and subcellular localisation of the
expressed proteinswas assessed by ﬂuorescent confocal microscopy. E2–CFP (cyan) and ChlR1–CFP (yellow) co-localise in the nuclear compartmentwith nucleolar exclusion as assessed
by stainingDNAwithHoechst 33342 (blue). Scale bar indicates 20 μm. (B) hTERT-RPE1 cellswere co-transfectedwith 10 ngRenilla Luciferase, 100 ngof the E2 responsiveﬁreﬂy Luciferase
reporter, 6E2-tk-Luc, and 0.1, 1, 10 or 100 ng of E2, E2–CFP or E2W130R–CFP expression plasmid. Luciferase activitywas determined as described inMaterials andmethods. The recorded
ﬁreﬂy Luciferase activity was normalised to the Renilla activity and the data shown represents the mean and standard deviation of three independent experiments. (C) Cell lysates taken
from the transcription assay described in (B) were separated by SDS-PAGE and the expression of E2 protein detected by Western blot using B201 (obtained from E. Androphy, Indiana
University). E2 and E2–CFP fusions proteins are indicated along with non-speciﬁc spurious bands (*), one of which runs immediately above the native E2 protein (visible in lane 4).
Molecular weight standards are indicated on the left.
3Rapid Communicationcheckpoint if genome integrity is lost. Nonetheless, the majority of the
metaphase spreads in the ChlR1 depleted sample displayed abnormal
sister chromatid cohesion (7 out of 9). In contrast, cells co-transfected
with ChlR1 siRNA to deplete endogenous ChlR1 protein and ChlR1–YFP
expression plasmid showed normal sister chromatid cohesion in the
majority of metaphase spreads analysed (16 out of 19). Representative
images are shown in Fig. 2B. These data indicate that the ChlR1–YFP
protein is able to functionally replace endogenous ChlR1.ChlR1 and E2 fusion proteins associate in vivo
After ensuring that E2 and ChlR1 fusion proteins were correctly
expressed, localised and retained wild type activity, an immunoprecip-
itation assay was performed to conﬁrm the interaction between ChlR1
and E2 fusion proteins. hTERT-RPE1 cells were co-transfected with
combinations of plasmids expressing C-terminally tagged ChlR1 and E2
proteins. Whole cell lysates were immunoprecipitated with E2 speciﬁc
Fig. 2. Functional analysis of ChlR1–YFP. hTERT-RPE1 cells were transfected with non-
targeting control siRNA (NT)or siRNA speciﬁc to the 3′UTRofChlR1. Cells transfectedwith
ChlR1 siRNA were also co-transfected with ChlR1–YFP expressing plasmid. (A) The
expression of endogenousChlR1 andChlR1–YFPwas compared to untransfected cells (UT)
by Western blot. Protein concentration of whole lysates was determined by BCA assay
(Pierce) and 30 μg total protein was separated by SDS-PAGE prior to Western blotting
using anti-ChlR1 antibody. Endogenous ChlR1 and ChlR1–YFP proteins are indicated along
with a spurious band (*), which runs close to the molecular weight of ChlR1–YFP.
Molecular weight standards are indicated on the left. (B) Metaphase chromosome
morphology was determined in each cell population by metaphase spread. DNA was
stained with propidium iodide and chromosomes visualised by confocal microscopy.
4 Rapid Communicationantibody B201, and the presence of co-precipitating ChlR1 protein was
detected by Western blot (Fig. 3). Co-immunoprecipitation of ChlR1–
YFPwith E2–CFPwas conﬁrmed, providing evidence that the C-terminalFig. 3. Co-immunoprecipitation of E2 and ChlR1 fusion proteins. hTERT-RPE1 cells were
co-transfected with constructs expressing E2–CFP and ChlR1–YFP, ChlR1–YFP alone or
E2W130R–CFP and ChlR1–YFP as shown.Whole cell extracts were immunoprecipitated
with E2 speciﬁc antibody B201 or non-speciﬁc FLAG antibody and the presence of co-
precipitating ChlR1 detected on the same membrane by western blot. The membrane
was then stripped and re-probed with β-actin antibody. The lower three panels show
10% input of the E2 and ChlR1 proteins for each co-immunoprecipitation reaction and
β-actin loading control.ﬂuorescent protein tag does not disrupt the interaction between E2 and
ChlR1. Conversely, co-immunoprecipitation of ChlR1–YFP with E2–CFP
was not observed when cell lysates were incubated with an irrelevant
antibody (FLAG), and ChlR1–YFP was not immunoprecipitated with E2
antibody from cells transfected with ChlR1–YFP alone. To further
validate the speciﬁcity of the interaction between E2–CFP and ChlR1–
YFP, cells were co-transfected with ChlR1–CFP and E2W130R–YFP.
While the E2W130R–CFP protein was efﬁciently immunoprecipitated
with B201 antibody, co-precipitating ChlR1–YFP was not detected,
providing evidence that the ﬂuorescent tags associated with these
proteins do not facilitate non-speciﬁc interactions between E2 and
ChlR1.
Characterisation of ChlR1 and E2 interaction in vivo using FRET
FRET is used to study protein–protein interactions and takes
advantage of a direct energy transfer between two closely associated
ﬂuorophores. In order for FRET to occur, proteins need to be within
10 nm of each other and therefore likely to be directly associated
(Piston and Kremers, 2007). To determine if E2 and ChlR1 are closely
associated, FRET efﬁciency between the CFP and the YFP moieties was
measured using confocal microscopy and the acceptor photobleach-
ing method. To validate our results, we used two negative and two
positive controls. Linked CFP–YFP fusion constructs, pCYa and pCYx
were used as positive controls. The donor alone (E2–CFP) and the
donor with free YFP were used as negative controls as no transfer of
energy occurs in the absence of the acceptor and between the donor
and the empty pYFP-C1 plasmid.
To determine the FRET efﬁciency between E2–CFP and ChlR1–YFP,
we examined individual regions of interest (ROIs) throughout the cell
and found that a positive FRET signal was only observed in the nuclear
compartment regardless of whether cytoplasmic staining of the
ﬂuorescent proteins was visible (data not shown). Therefore, for the
remainder of the FRET experiments described in this manuscript ROIs
within the nuclear compartment of co-transfected cells only were
chosen. As expected, a positive FRET efﬁciency was observed in cells
expressingCFP(x)7YFP andCFP(x)15YFP fusion proteins fromconstructs
pCYx and pCYa respectively and little or no FRET was observed when
cells were transfected with E2–CFP alone or E2–CFP and native YFP
(Fig. 4). Interestingly, cells expressing E2–CFP and ChlR1–YFP displayed
a positive average FRET efﬁciency of 16.05%, signiﬁcantly higher than
that observed with the negative controls and with a similar FRET
efﬁciency as that recorded between the CFP–YFP fusions used as a
positive control. Since FRET efﬁciency reduces as the distance between
the acceptor and the donor increases (Kenworthy, 2001), these dataFig. 4. Measurement of FRET between E2–CFP and ChlR1–YFP. hTERT-RPE1 cells were
transfected with plasmids expressing proteins as indicated on the x axis. FRET efﬁciency
was assessed using acceptor photobleaching method as described in the materials and
methods. The data shown represent the mean and standard deviation of 4 ROIs taken
from at least 33 individual cells (the number of cells (n) assayed in each data point is
indicated).
5Rapid Communicationprovide strong evidence that E2 and ChlR1 are in close molecular
proximity within the nuclear compartment. However, the large
standard deviation (±10.32%) within this data set suggests that either
the FRET signals in the nucleus are dependent on speciﬁc localisation or
that the association of E2 with ChlR1 depends on the physical state of
individual cells.
To further validate the positive FRET efﬁciency observed between
E2–CFP and ChlR1–YFP, cells were co-transfected with E2W130R–CFP
and ChlR1–YFP expressing plasmids. While both fusion proteins were
efﬁciently expressed in the analysed cells, only a very low FRET
efﬁciency between these two molecules was recorded (Fig. 4),
providing strong evidence that the positive FRET signal observed
between wild type E2–CFP and ChlR1–YFP is directly due to an
interaction between E2 and ChlR1 and not due to non-speciﬁc
ﬂuorescent energy transfer between CFP and YFP molecules that are
localised to the same cellular compartment.FRET efﬁciency between ChlR1 and E2 fusion proteins is dynamic
throughout the cell cycle
To determine the dynamic nature of the interaction between E2
and ChlR1 throughout the cell cycle, we performed FRET analysis on
cells which were arrested in G1 by serum starvation, early-S phase by
thymidine block, mid-S phase by thymidine block followed by a 3-h
release and in mitosis by incubation with nocodazole. The synchrony
of the cell populations was determined by ﬂow cytometry of
propidium iodide stained cells (Fig. 5A). To ensure that the fusion
proteins were expressed in all synchronised populations at levels
comparable to those observed in asynchronously growing cells, E2–
CFP and ChlR1–YFP expression levels were determined by Western
blot (Fig. 5B). While a small reduction in the expression of E2–CFP and
ChlR1–YFPwas observed in cells arrested in G1, the expression of both
fusion proteins was comparable in cells arrested at early S phase,
actively replicating DNA in mid-S phase, or in mitosis. Measurement
of the FRET efﬁciency between E2–CFP and ChlR1–YFP in cells
arrested in G1 by serum starvation revealed a positive FRET efﬁciency
of 10.42±5.12% (Fig. 5C). This FRET efﬁciency was maintained into S
phase (9.32±4.41%) and interestingly was signiﬁcantly increased as
cells progressed into mid-S phase (26.73%±7.29, p=1.36×10−12).
In contrast, cells arrested in mitosis showed a very low FRET efﬁciency
of 1.2±1.62% which is close to the efﬁciency observed in the
unbleached negative control (0.76±1.46%) and reﬂective of the loss
of co-localisation of the fusion proteins as cells enter mitosis (Fig. 5D).
This conﬁrms our earlier observation that E2 and ChlR1 do not co-
localise on chromosomes during mitosis (Parish et al., 2006a).
To conﬁrm these data and determine whether native E2 protein
associates with endogenous ChlR1 protein in a cell cycle dependent
manner, hTERT-RPE1 cells were transfected with an E2 expressing
plasmid. Twenty-four hours following transfection, cells were
removed from the tissue culture dish, pooled and reseeded to fresh
6 cm dishes. Cells were then arrested in G1 by serum starvation, S
phase by thymidine block, mid-S phase by thymidine block followed
by a 3- and 5-h release and in mitosis by incubation with nocodazole.
Cells were harvested and the association of E2with endogenous ChlR1
determined by co-immunoprecipitation with ChlR1 speciﬁc antibody.
The data in Fig. 6 show thatwhile endogenous ChlR1 protein levels are
similar in all cell populations, E2 protein is stabilised somewhat in
cells arrested in early S phase, as previously demonstrated (Johansson
et al, 2009). In agreement with the FRET data shown in Fig. 5,
immunoprecipitation with ChlR1 speciﬁc antibody in lysates from
synchronised cells shows that E2 associates with endogenous ChlR1
with the highest afﬁnity during mid-S phase (Fig. 6), thus providing
evidence that the strong FRET signal between E2–CFP with ChlR1–YFP
during mid-S phase does indeed reﬂect an increase in the association
of native E2 protein with ChlR1.Discussion
The data presented in this study provide strong evidence that E2
and ChlR1 directly associate in vivo and novel insight into the dynamic
and temporal nature of this interaction. ChlR1 and E2 proteins were
fused to YFP and CFP respectively. Correct expression, sub-cellular
localisation and function of the fusion proteins were conﬁrmed
(Figs. 1 and 2) and association of the recombinant proteins assayed by
co-immunoprecipitation (Fig. 3). Based on these data E2–CFP and
ChlR1–YFP were used in subsequent FRET experiments. The mea-
surement of the FRET efﬁciency between this protein pair revealed a
robust and signiﬁcant protein–protein interaction that was dramat-
ically reduced to levels observed with negative controls when the E2
mutant W130R CFP fusion was co-transfected with ChlR1–CFP. The
loss of FRET between E2W130R–CFP and ChlR1–YFP conﬁrms ﬁrstly
that this mutation disrupts that association of E2 with ChlR1 and also
that the FRET signal observed between E2–CFP and ChlR1–YFP is due
to speciﬁc association of E2 and ChlR1 and not aggregation of the
exogenously expressed fusion proteins. The FRET efﬁciency between
E2–CFP and ChlR1–YFP was surprisingly high and in line with that
observed with the positive controls. In addition, the heterogeneous
FRET efﬁciencies from cell to cell transfected with E2–CFP and ChlR1–
CFP reﬂected a large degree of variation in the efﬁciency of FRET
between E2 and ChlR1 in a mixed cell population, and led to the
hypothesis that the interaction between E2 and ChlR1 was dependent
on the speciﬁc cell cycle phase.
In order to test this hypothesis, cells were arrested in G1, early and
mid-S phase and mitosis, and the interaction between ChlR1 and E2
measured. A robust and signiﬁcant FRET efﬁciency between ChlR1–
YFP and E2–CFP was observed in G1 and early S phase, which
dramatically increased as cells progressed into mid-S phase (Fig. 5).
Interestingly no association of E2–CFP and ChlR1–YFP was detected in
cells arrested in mitosis. These data are conﬁrmed by co-immuno-
precipitation of E2 protein with endogenous ChlR1 in cells synchro-
nised in early and mid-S phase, with minimal association detected in
cells synchronised in G1 phase, late-S phase or mitosis (Fig. 6).
We have previously shown that E2 interacts with ChlR1 in order to
facilitate viral genome segregation during mitosis (Parish et al.,
2006a) but whether ChlR1 interaction is required for physically
tethering viral genomes onto mitotic chromosomes or for loading
genomes onto chromatin prior to mitotic segregation was unresolved.
Co-localisation data suggested the latter scenario since E2 and ChlR1
co-localise as chromosomes begin to condense, but not when cells
enter mitosis. The data presented here show that ChlR1 and E2 only
associate during G1 and S phase of the cell cycle and while the
interaction with ChlR1 is important for viral genome tethering,
interaction with other cellular proteins must be required for the
physical association of E2 with host cell chromosomes during mitosis.
Several candidate proteins involved in papillomavirus genome
segregation have been described including Brd4 and TopBP1. It will
be interesting to study the dynamics of these protein interactions in
live cells in order to determine their importance in the segregation of
viral DNA.
Several studies in budding yeast have shown that the ChlR1
homologue Chl1 associates with components of the cellular replication
machinery including replication factor C (RFC) and proliferating cell
nuclear antigen (PCNA) (Mayer et al., 2004; Moldovan et al., 2006;
Petronczki et al., 2004), and interactionwith theRFC complex stimulates
ChlR1 helicase activity (Farina et al., 2008). Depletion or mutation of
ChlR1 or the yeast homologue results in inefﬁcient sister chromatid
cohesion and defects in chromosome segregation (Gerring et al., 1990;
Inoue et al., 2007; Parish et al., 2006b; Skibbens, 2004). In addition,
ChlR1 physically associates with the cohesin complex (Inoue et al.,
2007; Parish et al., 2006b). Putting these data together it is thought that
ChlR1 function is required for sister chromatid cohesion establishment
duringDNA replication. Interestingly, ChlR1 also associateswith theﬂap
6 Rapid Communicationendonuclease Fen1 and Fen1 activity is stimulated by ChlR1, suggesting
that ChlR1 may play a role in the processing of lagging strands during
cohesion establishment (Farina et al., 2008).The recruitment of E2 and bound viral genomes to host cell
chromosomes must presumably occur before entry into mitosis. In
order to facilitate this, E2 targets the cohesion establishment pathway
Fig. 6. Cell cycle dependent association of BPV-1 E2 and endogenous ChlR1. hTERT-RPE1
cells were transfected with E2 expressing plasmid. Twenty-four hours following
transfection, cells were trypsinised, pooled and reseeded into fresh tissue culture dishes
at approximately 30% of their original density. Cells were then arrested in early-S phase (E-
S) by thymidine block or released from the thymidine block and harvested in mid-S phase
3 h post release (M-S) or in late S phase 5 h post release (L-S). Cellswere also arrested inG1
by serum starvation or inmitosis (M) by incubation in nocodazole. Ten percent input of the
whole cell extracts used for co-immunoprecipitation experiments is shown in the top two
panels indicating ChlR1 and E2 expression, respectively. Lysates were immunoprecipitated
with either HA (12CA5) antibody as a negative control or ChlR1 speciﬁc antibody and
immunoprecipitated ChlR1 protein on the upper half of the membrane is shown. The
presence of co-precipitating E2 protein, detectedwith B201 antibody is shown in the lower
panel. The lower half of eachmembranewas stripped and re-probedwith β-actin antibody
to show equal loading and speciﬁcity of protein co-immunoprecipitation.
7Rapid Communicationvia its association with ChlR1 and ensures that viral genomes are
tethered to chromosomes as the replication fork progresses during S
phase. Association between ChlR1 and E2 is then disrupted but E2
remains tethered to chromosomes via interaction with another
cellular protein or protein(s). Elucidation of this intriguing mecha-
nism of passing viral episomes to daughter cells and ensuring nuclear
retention will not only help in the understanding of host cell
chromosome segregation but also provide a useful clinical target in
the design of novel antiviral therapeutics.
Materials and methods
Cell culture
hTERT-immortalised human retinal pigment epithelial cells (hTERT-
RPE1)weremaintained in 50%Dulbecco's Eagle'sModiﬁedMediumand
50% F-12 (DMEM/F-12) supplemented with 10% foetal bovine serum.
Cells were transfected using Fugene DH (Roche) at a DNA/Fugene ratio
of 1:3. For synchronization, cells were treatedwith serum-freemedium,
2 mM thymidine or 100 ng/ml nocodazole for 16 h. For thymidine
release experiments, cells were washed three times with 37 °C PBS and
fresh 37 °Cmediumadded. Cellswere then harvested 3 h post release to
obtain a population of cells synchronised in mid-S phase.
Constructs
pcDNA3-ChlR1–CFP expresses human ChlR1 fused to CFP at the
C-terminal end of ChlR1. pcDNA3–E2–YFP expresses BPV-1 E2 fused toFig. 5. Measurement of the association of E2 and ChlR1 at speciﬁc stages of the cell cycle. (A
arrest by serum starvation, synchronisation in early and mid S phase arrest by thymidine
compared to asynchronous population. (B) The expression level of E2–CFP and ChlR1–YFP in
as above and lysed. Equal amounts of protein from the whole cell extracts were separate
antibodies. (C) FRET efﬁciency of E2 and ChlR1 interaction in hTERT-RPE1 cells transfected
described in thematerials andmethods. The data shown represents the mean and standard d
in each data point is indicated). (D) Subcellular localisation of the expressed proteins in sy
ChlR1–CFP (yellow) co-localise in the nuclear compartment with nucleolar exclusion as assYFPat theC-terminal endof E2. pcDNA3–E2W130R–YFP expresses BPV-
1 E2 W130R fused to YFP at the C-terminal end of E2. pEYFP-C1
(Clontech) expresses YFP. pCYx and pCYa (obtained from Dr. Laura
Trinkle-Mulcahy, College of Life Sciences, University of Dundee) express
CFP fused toYFPwith7 and15 aminoacid spacers respectively andwere
used as positive controls for FRET experiments. pRL-CMV (Promega)
constiutively expresses Renilla luciferase and p6E2-tk-Luc (obtained
from Professor Iain Morgan, University of Glasgow) contains 6 E2
binding sites upstream of the gene encoding ﬁreﬂy Luciferase.
Antibodies
The N-terminal 1–130 amino acids of ChlR1 were cloned into
pET24b using NdeI and XhoI restriction sites. The resulting pET24b-
130-ChlR1 expresses ChlR1 1–130 with a hexahistidine tag at the C-
terminus (LEHHHHHH). pET24b-130-CHlR1 was transformed into
Rosetta(DE3)2 pLyS Escherichia coli (Novagen) and expressed at 30 °C
for 3–4 h after induction with 0.5 mM IPTG. Cells were harvested and
pellets resuspended in lysis buffer (20 mM Tris–HCl, pH 8.0, 250 mM
NaCl). Lysis was performed at room temperature using lysosyme
(Sigma), followed by a 20-s sonication at 4 °C, 70% amplitude. The
lysate was then cleared by centrifugation at 10,000g for 15 min at 4 °C
and the supernatant loaded onto a HiTrap-Chelating HP column
charged with Ni2+ (GE Healthcare). After washing with 10 column
volumes of wash buffer (phosphate buffer pH 7.4, 500 mM NaCl,
60 mM imidazole), the puriﬁed protein was eluted with the same
buffer containing 250 mM imidazole. Protein purity was assessed by
SDS-PAGE and concentration determined by BCA assay. Protein was
stored at 4 °C in 20 mM Tris–HCl buffer pH 8.0, 100 mM NaCl, 1 mM
DTT. On average 26 mg of protein with 98% of purity was obtained
from 500 ml of bacterial culture. Antibodies to ChlR1 1–130 were
raised in rabbits by Dundee Cell Products and afﬁnity puriﬁed on
protein G sepharose resin.
B201 antibody recognises BPV-1 E2 (provided by Elliot Androphy,
University of Indiana, USA). FLAG and β-actin antibodies were
purchased from Sigma. Secondary horseradish peroxidase conjugated
anti-mouse and anti-rabbit antibodies (Jackson ImmunoResearch)
were detected using Supersignal West Dura (Pierce).
Transcription assays
hTERT-RPE1 cells were seeded into 6 well plates at a density of
1×105 and co-transfected with 10 ng pRL-CMV, 100 ng p6E2-tk-Luc
and 0.1, 1, 10 or 100 ng of E2 expression plasmid. The amount of DNA
in each transfection was normalised to 250 ng with salmon sperm
DNA. Cells were harvested 24 h following transfection and lysed in
100 μl passive lysis buffer (Promega). Luciferase activity was
measured in a 96 well Fluorostar Optima luminometer (BMG Labtech)
using a Dual Luciferase assay kit (Promega) following the manufac-
turer's instructions. Each experiment was performed in triplicate.
RNA interference
hTERT-RPE1 cells were seeded into 60 mm tissue culture dishes at
a density of 200,000 cells per dish in antibiotic free growth medium.
Five hours later, cells were transfected with 100 nM non-targeting
siRNA (iGENOME Non-Targeting siRNA #2, Thermo Fisher Scientiﬁc)) The synchrony of hTERT-RPE1 cells expressing ChlR1–CFP and E2–YFP following G1
block or nocodazole-induced mitotic arrest was determined by ﬂow cytometry and
each cell population analysed was determined by western blot. Cells were synchronised
d by SDS-PAGE. The membrane was then probed with ChlR1, E2 and β-actin speciﬁc
and synchronised as in (A) was assessed using the acceptor photobleaching method as
eviation of 4 ROIs taken from at least 19 individual cells (the number of cells (n) assayed
nchronised cells was assessed by ﬂuorescent confocal microscopy. E2–CFP (cyan) and
essed by co-staining the DNA with Hoechst 33342 (blue).
8 Rapid Communicationor ChlR1 3′ UTR speciﬁc siRNA (5′-AGUCACUCCUUCAGUAGAAUU-3′)
using JetPRIME™ reagent, using 6 μl JetPRIME™ reagent per trans-
fection and following the manufacturer's instructions (Polyplus
Transfection Inc). Co-transfectionwith ChlR1–YFP expression plasmid
was performed by adding 500 ng of pcDNA3–ChlR1–CFP to the
transfection mix at the same time as adding the siRNA oligonucleo-
tide. Cells were then incubated for 24 h.
Chromosomal spreads
siRNA transfected cells were blocked with 100 ng/ml nocodazole
for 3 h and swelled in hypotonic buffer (0.8% sodium citrate) for
10 min at room temperature. Cells were ﬁxed in Carnoy's ﬁxative
(75% methanol, 25% acetic acid) and spreads prepared by dropping
suspended cells onto slides warmed to 37 °C. Slides were then stained
with 1 mg/ml propidium iodide in PBS and mounted in Prolong
Antifade (Invitrogen).
Co-immunoprecipitation assays
Cells were lysed for 30 min in freshly prepared lysis buffer (50 mM
Tris–HCl 7.4, 100 mM NaCl, 20 mM NaF, 10 mM KH2PO4, 1% triton,
0.1 mMDTT, 10% glycerol and protease inhibitors (Sigma)). Cells were
sonicated 2×10 s at 70% amplitude and cleared by centrifugation. For
co-immunoprecipitation, 200 μl of lysate was mixed with 200 μl
binding buffer (50 mM Tris–HCl 7.4, 100 mM KCl, 0.1 mM EDTA, 0.2%
NP40, 0.1% BSA, 2.5% glycerol, 2 mM DTT and protease inhibitors),
10 μl of protein G sepharose (Sigma) and appropriate antibody.
Samples were incubated at 4 °C for 2–3 h with gentle agitation
followed by 3 washes with wash buffer (100 mM Tris–HCl 7.4,
100 mM NaCl, 0.5% NP40, 2 mM DTT and protease inhibitors). Co-
immunoprecipitating proteins were separated by SDS-PAGE and
detected by Western blot. Membranes were subsequently stripped
and re-probed with β-actin antibody.
Fluorescence microscopy
Cells were cultured on coverslips. At 24 h post-transfection, cells
were ﬁxed in 4 % paraformaldehyde and nuclei stained with 5 μg/ml
Hoechst 33342 (Molecular probes, Invitrogen) for 10 min. Coverslips
were mounted on slides with Prolong Antifade (Invitrogen) and then
sealed. Images were captured using a Leica TSC SP2 AOBS confocal
laser scanning microscope.
FRET microscopy
FRET measurements were collected using the acceptor photo-
bleaching method (Kenworthy, 2001). Cells were grown on glass
bottomed dishes, coated with collagen (rat tail, type 1, Millipore) and
were co-transfected with CFP and YFP fusion proteins at a 4:1 ratio.
Images were captured using a Leica TSC SP2 AOBS confocal laser
scanning microscope and a 63× oil immersion objective in a 37 °C
chamber. The Krypton/Argon laser was set at 458 nm, 50% intensity to
excite the CFP and at 514 nm, 50% and 100% intensity to excite and
photobleach the YFP, respectively. CFP ﬂuorescence was detected at
465–505 nm and YFP at 525–600 nm. Acceptor photobleaching was
performed by stationary laser pulses of 150 ms at 514 nm, until 80%
photobleaching was achieved. For all data points at least 7 individual
cells were analysed with at least 4 regions of interest (ROIs) drawn in
each.
Images were acquired using Leica acquisition and analysis
software. Bleached regions, unbleached regions in the nucleus and
regions outside the compartment of interest were selected to deﬁne
background ﬂuorescence. Because of the fast diffusion of unbleached
acceptor molecules in the bleached regions, donor quenching was
detected in a very short period of 1 s after photobleaching, acquiringpost-bleaching images after 2 ms. FRET efﬁciency was calculated




Where Dpost is the ﬂuorescence intensity of the donor after
acceptor photobleaching and Dpre is the ﬂuorescence intensity of the
donor before accepter photobleaching.
Flow cytometry
Cells were ﬁxed with 5 ml of 70% ethanol, washed with PBS and
labelled with 50 μg/ml propidium iodide containing 0.1 mg/ml RNase
A in PBS for 30 min. Data were acquired using a FACScan ﬂow
cytometer (BD Biosciences) and analysed using Summit® v3.1
(DakoCytomation).
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